Equity Brief · Healthcare2026-05-20
RMD·Healthcare

ResMed Inc

I · Análisis con IA

En breve

ResMed manufactures devices that help people breathe better during sleep—primarily CPAP machines and other equipment for sleep apnea—and also sells cloud-based software that home health agencies, nursing homes, and medical equipment suppliers use to manage patient records and billing [Yahoo Finance]. They operate in two main segments: Sleep and Breathing Health (the devices) and Residential Care Software (the healthcare management systems).

ResMed is a $30.1 billion medical device company that makes equipment to treat sleep apnea and other breathing disorders, along with software for home healthcare providers [Yahoo Finance]. The company just announced a partnership with Oura, a wearable ring maker, to screen for sleep problems earlier and expand its customer base beyond traditional doctor referrals [Simply Wall St]. Financially, ResMed is exceptionally strong with 27% profit margins, $1.7 billion in free cash flow, and a perfect 10/10 health score [Yahoo Finance].

ResMed is in outstanding financial shape with strong profitability, excellent cash generation, and essentially no net debt.

En breve AI analysisConfianza 8/10

Puntuación Sentinellis

10/10

Financially healthy

Capitalización bursátil

$30.1B

Ingresos (12 meses)

$5.1B

II · Noticias recientes

Qué movió el precio

3 stories · ranked by relevance

  • macro2026-05-20

    ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access

    Simply Wall St

  • macro2026-05-19

    Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

    Yahoo Finance

  • macro2026-05-19

    Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

    Yahoo Finance

Premium · gratis con cualquier cuenta

The stock has declined nearly 20% over the past three months despite strong fundamentals, indicating investors may be concerned about growth sustainability or competitive pressures not yet visible in the financial data [Simply Wall St].

1 de 4 riesgos en este informe

Riesgos

4

Oportunidades

4

Señales de alerta

1

Dirección

10

18 hallazgos más en el informe completo — gratis con cualquier cuenta.

Desbloquea el análisis completo de ResMed Inc

Crea una cuenta gratuita para acceder al informe completo generado con IA, con fuentes citadas en el texto.

  • 4 riesgos, 4 oportunidades y 1 señal de alerta — cada uno con su fuente
  • Más de 100 métricas financieras con gráficos y comparativas
  • Resúmenes completos de noticias con enlaces a las fuentes
  • Equipo directivo y remuneración
  • Exportación a PDF para leer sin conexión
Desbloquea los 9 hallazgos3 informes gratis · sin tarjeta

III · Empresas similares

También te puede interesar

Same sector · Healthcare or comparable health

¿La añades a tu lista?

Read three companies free. Sin tarjeta.

Consigue 3 informes gratis